Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TPTE2 pseudogene 4 (TPTE2P4)
- Target
- TPTE2P4
- Molecular classification
- Other (pseudogene); not a receptor, enzyme, transporter, or transcription factor
01
Overview
TPTE2 pseudogene 4 (TPTE2P4) is a member of the TPTE2 gene family but lacks a protein-coding function, classified as a pseudogene. Unlike protein-coding TPTE2, which acts as a membrane-associated phosphoinositide phosphatase with tumor suppressor-like activities, TPTE2P4 does not encode an active enzyme and has no established biological or clinical role. Pseudogenes may occasionally be transcribed, but typically do not produce functional protein, and are not considered viable molecular targets for therapy or diagnostics. If the intent was to find a functional protein target, TPTE2 or its splice variants ("transmembrane phosphoinositide 3-phosphatase and tensin homolog 2", abbreviated as TPTE2 or TPIP) would be the correct choice, not TPTE2P4.
- Other names
- TPTE2P4transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 pseudogene 4TPTE pseudogene 4TPIP pseudogene 4
02
Mechanism of action
None (not a target for therapeutic drugs)
03
Biological functions
Other (no known biological function; likely non-functional); functional TPTE2 family members are involved in cell proliferation and apoptosis regulation
04
Disease associations
Other (no established disease association); research on functional TPTE2 family members links them to cancer suppression roles, but not for pseudogene members like TPTE2P4
05
Safety considerations
None (no therapeutic interventions or safety profile relevant)
06
Interacting drugs
None (no known drugs interact with pseudogenes; functional TPTE2 may be considered for drug targeting in oncology)
07
Biomarkers
None (not used as a biomarker)
Beyond the preview
Go deeper on TPTE2 pseudogene 4 (TPTE2P4).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TPTE2 pseudogene 4 (TPTE2P4).